Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
William Beaumont Hospital, a Detroit-area hospital system, will pay $84.5 million to settle allegations of violating the Anti-Kickback Statute for improper relationships with eight referring physicians.
Overcoming addiction is a full-time, around-the-clock endeavor. The triggers for relapse could come from anywhere—whether that be running into an old friend, facing unexpected emotional difficulties or ending up in locations tied to drug use.
A new technology hopes to break the geographical barriers keeping patients from diagnostic CT scans. The imaging units are hardly mobile, so one scientist is hoping to put similar tools into people’s hands.
The aftereffects of a hospitalization can leave many patients in a vulnerable state known as “post-hospital syndrome” that increases the likelihood of a readmission, The New York Times reported.
The global market for artificial intelligence (AI) in medical imaging is expected to see significant growth in the years ahead, topping $2 billion by 2023, according to a new report from Signify Research.
Genetic testing companies, including Ancestry and 23andMe, have agreed to new rules when it comes to sharing customers’ DNA with third-party companies.
Scientists have discovered a new type of cell—one that could radically change how researchers see cystic fibrosis. As part of a cellular mapping project, scientists identified a rare cell type that could affect rehydration and pH balance, which are integral to those with cystic fibrosis.
The stock price of health insurance giant Humana shot above $325 per share on Wednesday, August 2—a new record high—after its second-quarter earnings release.
